2023 Annual Conference

Chicago, IL
September 18th - 20th, 2023

IHFDA 7th Annual Conference

This is a Hybrid (In-person & Virtual) event

IHFDA is pleased to announce the 2023 annual conference this year in the Chicago area.  The dates are September 18-20, 2023 at the Chicago Westin O’Hare in Rosemont, Illinois.

As in the past, the agenda will be packed full of the most up-to-date information on the diversion of medications in healthcare facilities. Look for a full agenda soon along with exhibitor opportunities.

IHFDA will also be offering the Fundamental Drug Diversion Course this year after the large attendance and positive feedback in 2022. In addition, the course is being improved with updated and additional training content within the diversion space. More information is available below.

The conference is available as in-person or hybrid, the diversion course is virtual with a live (in-person & virtual) Q&A with the panel.

Conference Attendee $400
Conference Registration
Speaker / Corporate Member
Other Registration
Hotel Reservations

Call for Proposals & Presentations

IHFDA’s conference planning committee seeks abstracts for podium, poster, and panel presentations that address topics on diversion, risk management, quality practice, and guidelines/processes used to increase the knowledge and skills of all professionals and promote the development of our profession. Proposals on any major topic related to healthcare facility diversion are welcome for consideration.

Presentation Information

Fundamental Drug Diversion Certificate

Fundamental Drug Diversion Certificate Agenda
"Drug Diversion: Personal Impacts, Patient Harm and Unexpected Outcomes” (1 hour)

“Overview of Institutional Drug Diversion” (1 hour)

“Drug Diversion Interviews in Healthcare: Gateway to the Truth” (1 hour)

“The Public Health Perspective: Injectable Drug Diversion and Bloodborne Pathogens Transmission” (1 hour)

“Developing a Comprehensive Drug Diversion Monitoring Program” (3 hours)

“The Intersection of Peer Support and Substance Use Disorder in Nurses” (1 hour)

About Fundamental Drug Diversion Certificate
The IHFDA Executive Board is proud to once again offer the fundamental course on drug diversion inside healthcare facilities. This groundbreaking 8-hour compilation of some of the most experienced and trusted experts in this field should prove extremely helpful whether you are just starting to seriously look at drug diversion inside your institution or you have been doing it for several years.

IHFDA has updated and added new training content from last year, and we feel that this course will address the main concerns of everyone who is tasked with these crucial investigations, with the ability to ask questions of the actual presenters. The presenters are either currently working on drug diversion inside a healthcare facility, or have spent many years in the field.

This is something many of you in the field have been asking for years to be available for your new people into this area of investigation and those who desire a refresher course while also seeing the most recent methods and means of today’s investigators.

The first offering of this course will provide continuing education credits.  The cost for the virtual course is  $200.
Full Details about the Fundamental Drug Diversion Certificate

Conference Agenda

Download Agenda
**Agenda is subject to change**
Day 1
Day 2
Day 3
Poster Presentations
9/26/2022 - Monday 
10:00 A.M. - 11:30 A.M.
Fundamental Drug Diversion Certificate Panel Discussion & Final Remarks
**Attendance is restricted to certificate participants only**
12:00 P.M. – 12:30 P.M.
Welcome and Opening Remarks – Start of Annual Conference
12:30 P.M. – 1:30 P.M.
“The Stairs on Billy Buck Hill”
Dr. Steven Orebaugh, University of Pittsburgh
1:30 P.M. – 2:30 P.M.
“The Discovery of a Complex “Look-a-like” Medication Swap Diversion Scheme and the Associated Outcomes"
Adam Beeler, The University of Kansas Health System
2:30 P.M. – 2:45 P.M.
2:45 P.M. – 3:45 P.M.
"Just or Unjust: How Organizational Culture Impacts the Healthcare Worker with Substance Use Disorder During a Drug Diversion Investigation"
Amanda Hays Becton, Dickinson and Company

Becky Doerhoff, Barnes-Jewish Hospital
3:45 P.M. – 5:15 P.M.
Topic Focused Session:
Road Map for Diversion Investigation Employee Interviews
Cory Luper & Michael Carico, Atrium Health Wake Forest Baptist

Discussing Processes and Demonstrating Skills Required for Interviewing
Terri Vidals & Bethanie Gamble, Rxpert Solutions
5:15 P.M. – 5:30 P.M.
Closing Remarks
5:30 P.M. – 6:30 P.M.
Networking / Social Hour & Time with Exhibitors
Drinks and Light Snacks - In The Exhibitor Hall
9/27/2022 - Tuesday
9:00 A.M. – 9:30 A.M.
IHFDA Membership Meeting and Business Updates
9:30 A.M. – 10:30 A.M.
“Wasting Time: Perioperative and Post-Discharge Medication Management, Wasting, and Patient Returns, Altering the Trajectory of the Opioid Crisis”
Jeffrey Wahl & Dr. Evan Kharasch, MIDAS Healthcare Solutions, Inc.
10:30 A.M. – 11:30 A.M.
"Ready for my Close Up! Implementing, Maintaining, and Expanding Drug Diversion Prevention Cameras"
Jesus Rodriguez, Jeremy Quinn, Shawn Young, & John Bailey
St. Jude Children’s Research Hospital
11:30 A.M. – 12:15 P.M.
Lunch & Time with Exhibitors
12:15 P.M. – 1:15 P.M.
"Drug Diversion Prevention Shouldn’t End at Termination: Why We Must Report All Diversion"
Rajesh Speer, UAB School of Medicine
Lauren Lollini, IHFDA
1:15 P.M. – 2:45 P.M.
Topic Focused Panel: Drug Testing
Bill Bundy, Millennium Health (Toxicologist – SME)
Michael Kalisher, UC Health (Random Drug Testing)
Alecia Pittman, Cooper University Health Care (For Cause Testing)
2:45 P.M. – 3:30 P.M.
Poster Presenter Session & Break
3:30 P.M. – 4:30 P.M.
"Enhancing a Drug Diversion Prevention Program: The Impact of Guidelines and Lean Tools"
Sharon Coffie & Elizabeth Daniel, UT Southwestern Medical Center
4:30 P.M. – 6:00 P.M.
Topic Focused Session:
 A Second Chance for Success, De-Stigmatization of Frontline Diversion Detection and Employee Assistance at a Large Academic Health-System
Alexandre Raymond & Cindy Mousa, Ochsner Health

Alternative to Discipline, An Opportunity for Change
Stephen Webster, University of Rochester Medical Center
6:30 P.M. – 11:00 P.M.
Free 32 passenger shuttle to-From Downtown Nashvile
IHFDA is providing a free shuttle from the conference hotel to the Omni Nashville (just two blocks from Broadway).  The shuttle will start at 6:30 pm from Franklin to Nashville (7:30 pm, 8:30 pm, 9:30 pm, 11 pm). Return trips to Franklin will start 8 pm, 9 pm, and 10 pm.
9/28/2022 - Wednesday
9:00 A.M. – 9:15 A.M.
Opening Remarks
9:15 A.M. – 10:15 A.M.
"Experience from Cross-Program, Multidisciplinary Team Investigations of Injectable Drug Diversion in Tennessee to Raise Awareness of Bloodborne Pathogen Transmission, 2020-2021"
Christopher Evans & Shirley Pickering, Tennessee Department of Health
10:15 A.M. – 11:45 A.M.
Topic Focused Panel: Medication Waste Testing
Testing for Suspicion & Medications Removed from Facility
Sushmita Shankar, Southern Illinois Healthcare

Perioperative Testing
Danielle Neal & Leah Mitchell, Atrium Health Wake Forest Baptist

Anesthesiology Waste Testing
Karen Kist, Nemours Children’s Health
11:45 A.M. – 12:30 P.M.
Lunch – Poster Sessions & Exhibitors
12:30 P.M. – 1:30 P.M.
"The Six Rights of Wasting: Decreasing the Opportunity for Diversion"
Fara Bowler, UC Health
1:30 P.M. – 2:30 P.M.
"The Value of Routine Cycle Counts"
Maureen Burger & Colleen Connelly, Visante Consulting LLC
2:30 P.M. – 2:45 P.M.
2:45 P.M. – 3:45 P.M.
"NIH Funded Research Summarizing the Value of Drug Diversion Software in Health Systems"
Tom Knight, Invistics
3:45 P.M. – 4:45 P.M.
What to Expect: DEA On-Site Inspection
Dwayne Jeffcoat, DEA
4:45 P.M. – 5:00 P.M.

On the Road Again: The Diversion Challenges and Solutions with Float and Travel Staff
Susie Aboulhosn & Melissa Inscoe, Vanderbilt University Medical Center
Development of an Effective Compliance and Surveillance Program
Caroline Carter & Sheetal Patel-House, UNC Health
The Limitations of Report-Based Systems: Results of One Facility’s Drug Diversion Implementation
Kenneth Mishark, Mayo Clinic Arizona
It Takes a Village: How Networking and Collaboration Strengthen a Diversion Prevention Program
Jodi Emmett, Sarasota Memorial Healthcare System
Denise Hickey, Tampa General Hospital
Holly Borkowski, Lee Health, Fort Myers
Uncharted Territory: Drug Diversion Prevention in the Care Continuum
Amanda Hays, Becton, Dickinson and Company
Selection and Implementation of a Drug Diversion Software Application to Enhance Current Drug Diversion Surveillance in a Not-for-profit Health Care System
JoAnne Myhre, Allina Health
Healthcare System Centralized Drug Diversion Services
Danielle Neal & Leah Mitchell, Atrium Health Wake Forest Baptist

Conference Exhibitors (A-Z)

ARL Bio Pharma Logo
BD Logo
HelioMetrics Logo
IMI Logo
PharmID Logo
Protenus Logo
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram